e-learning
resources
ERJ
2015
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The Rotterdam study: why fall in COPD?
Lahousse Lies, Verlinden Vincentius J.A., Ikram M. Arfan, Brusselle Guy G.
Source:
Eur Respir J 2015; 46: 1530-1531
Journal Issue:
November
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Lahousse Lies, Verlinden Vincentius J.A., Ikram M. Arfan, Brusselle Guy G.. The Rotterdam study: why fall in COPD?. Eur Respir J 2015; 46: 1530-1531
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Evidence-based eHealth for COPD
Related content which might interest you:
GOLD classifications and mortality in COPD: The HUNT study
Source: Annual Congress 2013 –Investigating COPD in longitudinal studies
Year: 2013
The effect of the indicated use of ß-blockers on the risk of COPD exacerbations: the Rotterdam Study
Source: Virtual Congress 2020 – Advances in pharmacological treatment of COPD
Year: 2020
Prevalence and incidence of COPD: The Rotterdam study
Source: International Congress 2015 – Prevalence of respiratory disease
Year: 2015
The Spanish national clinical audit on COPD exacerbations (eCOPD). Pilot study: selection of study subjects
Source: Annual Congress 2008 - COPD in the elderly - quality of life and scores in COPD
Year: 2008
COPD symptoms/diagnoses and work exposure: A 20 years population-based survey
Source: International Congress 2015 – COPD and lung function: risk factors and outcomes
Year: 2015
Measuring exacerbations in subjects with mild to moderate COPD from a population-based cohort: The CanCOLD study
Source: Annual Congress 2013 –Factors associated with outcomes in COPD
Year: 2013
Statins and mortality in COPD in the COMIC study: A prospective COPD cohort study
Source: International Congress 2016 – Novel avenues in the treatment of COPD II
Year: 2016
Characteristics of subjects susceptible to exacerbation-like respiratory events in a population-based cohort: Canadian cohort obstructive lung disease (CanCOLD) study
Source: International Congress 2014 – Longitudinal studies of respiratory disease
Year: 2014
Undiagnosed COPD: who is at risk, and does it matter? The Guangzhou biobank cohort study (GBCS)
Source: Annual Congress 2009 - Methodological aspects of asthma and COPD epidemiology
Year: 2009
Smoking reduction and hospitalization from COPD: a Danish population study
Source: Eur Respir J 2001; 18: Suppl. 33, 484s
Year: 2001
Prevalence of common diseases in COPD patients versus lung-healthy control subjects: Results from the German COSYCONET study
Source: International Congress 2016 – Comorbidities and exacerbations in COPD
Year: 2016
Risk of cardiovascular events following COPD hospitalisation: Findings from the China Kadoorie Biobank cohort study
Source: International Congress 2015 – COPD and lung function: risk factors and outcomes
Year: 2015
The ICE study, Italian costs for exacerbations in COPD: a project of the Italian Association for COPD
Source: Annual Congress 2003 - Outcome of acute exacerbations in COPD
Year: 2003
Night time dyspnea in COPD: A study of a general population
Source: Annual Congress 2013 –Risk factors for COPD and lung function decline
Year: 2013
Impact of frailty on interpretability of spirometry: The Rotterdam study
Source: Annual Congress 2013 –Assessing the prevalence of COPD in the general population
Year: 2013
The lifetime risk of developing COPD. The Rotterdam study
Source: Annual Congress 2008 - Environmental risk factors for respiratory symptoms and COPD
Year: 2008
Mortality rates in individuals with asthma, COPD and ACOS in a large population-based cohort: Is gender important?
Source: International Congress 2016 – Asthma, COPD, and ACOS: physical activity, dietary aspects, and diseases burden
Year: 2016
Pilot of a population cohort for the study of the natural history of COPD and OSAS: the pulsaib study
Source: Annual Congress 2009 - Comorbidities and case management in primary respiratory care
Year: 2009
Experience of work with patients with COPD
Source: Annual Congress 2013 –Improving educational programmes for patients and multidisciplinary healthcare professionals
Year: 2013
Treatment of COPD in general practice: the COOPT study
Source: Eur Respir J 2001; 18: Suppl. 33, 348s
Year: 2001
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept